AzTrials
AzTrials

Anterior Cruciate Ligament ReconstructionSyncGaitNCT07243535

Fractal vs Isochronous Cueing in Athletes After ACL Reconstruction

A study testing Fractal Cueing and Isochronous Cueing in people with Anterior Cruciate Ligament Reconstruction and Anterior Cruciate Ligament Reconstruction Rehabilitation, run by Egas Moniz - Cooperativa de Ensino Superior, CRL at 1 site in Portugal.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Anterior cruciate ligament (ACL) injuries are among the most prevalent and functionally limiting knee injuries in sports, particularly those that involve pivoting movements. Despite advancements in surgical reconstruction and physical rehabilitation, many athletes continue to exhibit persistent motor control deficits… Read more about this study

Who is it for?
Ages 15 to 35 years
What is being tested?
Fractal Cueing and Isochronous Cueing
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
1 sitePortugal
Study dates
3 Oct 2025to Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 35 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Undergone unilateral ACL reconstruction less than 2 years ago;
  • Have medical release for the full load on the injury limb for at least 2 weeks;
  • Be independently pain-free walking;
  • Being sports athletes according to an athlete description: Training regularly to improve performance, actively participating in competitions or formally registering in a sports federation or association;
  • Must be able to understand and perform the requested task.

Who cannot join

  • Participants with previous surgery on either knee;
  • Those with more than 3 months between ACL injury and surgery;
  • More than 2 weeks between surgery and the start of physical therapy;
  • Had another musculoskeletal injury in the lower limb within the past 6 months;
  • Another musculoskeletal surgery within the past 18 months;
  • Participants with a history of movement system pathologies, such as nervous system, cardiovascular, pulmonary, integumentary, or endocrine conditions;
  • Participants with vestibular or somatosensory system pathologies or visual impairments limiting their ability to see the metronome required for the task;
  • Use of medications that could affect locomotion and balance.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Inês D Ribeiro, MSC Student contact

(+351) 964 544 607

115360@alunos.egasmoniz.edu.pt

Catarina S Pino, MSC Student contact

(+351) 937 780 194

118878@alunos.egasmoniz.edu.pt

Portugal1 site, 1 recruiting
  • Egas Moniz School of Health & Science

    Almada, Monte de Caparica, 2829-511

    Inês Gomes, rso.cieem@egasmoniz.edu.pt

    Recruiting

Other trials in Portugal

About this study

Official title: Comparison Between a Session of Walking Synchronized to Fractal- VS Isochronous-Based Cues on Gait Variability and Corticospinal Measures in Athletes With a Reconstructed Anterior Cruciate Ligament: A Crossover Randomized Controlled Trial

Anterior cruciate ligament (ACL) injuries are among the most prevalent and functionally limiting knee injuries in sports, particularly those that involve pivoting movements. Despite advancements in surgical reconstruction and physical rehabilitation, many athletes continue to exhibit persistent motor control deficits and increased gait variability, both of which are closely linked to a heightened risk of re-injury and long-term joint degeneration. These deficits arise from biomechanical impairments and disrupt proprioceptive input that requires cortical reorganization, contributing to maladaptive neuroplasticity. However, conventional rehabilitation strategies often overlook this neural dimension. Recent findings emphasize the importance of fostering motor variability and promoting neuroplasticity through external focus strategies, including sensorimotor synchronization. While isochronous cues, an invariant stimulus, are commonly used, they do not reflect the natural fluctuations of healthy gait and may reduce its complexity. Fractal-based cues, in contrast, introduce structured variability resembling the natural dynamics of locomotion and have been shown to restore gait complexity in clinical populations. However, no study has yet explored their acute effects on gait variability and corticospinal function following ACL reconstruction (ACLR). This crossover randomized controlled trial aims to compare the acute effects of a single session of treadmill walking synchronized to either fractal or isochronous-based visual cues on gait variability and corticospinal measures in athletes with ACLR. The investigators hypothesize that fractal-based cueing will acutely restore gait variability and enhance corticospinal excitability, evidenced by increased corticospinal excitability and intracortical facilitation, and reduced short-interval intracortical inhibition, thus promoting adaptive neuroplasticity. Conversely, isochronous cueing is expected to maintain or decrease gait complexity without improving corticospinal measures. This study may provide insights that could be highly valuable as a way to promote neuroplasticity and optimize gait rehabilitation after ACLR, also allowing an objective quantification and aiming to restore variability to levels close to those observed in healthy individuals, thus contributing to reducing the re-injury rate.

Read the detailed description

This study will test a laboratory-based intervention using gait trials with sensorimotor synchronization, a common approach in gait rehabilitation aimed at restoring or acutely modifying gait variability. The intervention, called SyncGait, consists of treadmill walking synchronized with visual cues. Following a crossover design, each participant will complete two sessions, one with fractal cueing (FRC) and one with isochronous cueing (ISO), with the order randomized. Each cued trial will last 12 minutes and will be preceded and followed by uncued walking trials. The visual cues will be presented as a moving bar on a screen positioned in front of the treadmill. For the FRC condition, the cues will be individualized to each participant's stride time variability, generated through a fractal algorithm and validated using detrended fluctuation analysis. For the ISO condition, cues will match each participant's average stride time without variability. Participants will be instructed to synchronize heel strikes of the reconstructed limb with the top of the moving bar. The treadmill (Bertec Inc., USA) will record gait data at 1000 Hz. Each session will be conducted individually, supervised by at least two trained team members. A sample size of 36 participants was determined to ensure adequate power (90%) to detect a moderate effect size (ηp² = 0.25) at a 5% significance level, accounting for an anticipated 20% dropout rate. To encourage participation and retention, participants will receive a personalized evaluation report and a free isokinetic assessment within 12 months. Data collection will include both gait and corticospinal outcomes. Gait variability will be analyzed from treadmill force data, focusing on stride intervals and synchronization performance. Corticospinal outcomes will be assessed using transcranial magnetic stimulation (TMS) with a BiStim2 stimulator (Magstim®, UK). Electromyography (Delsys Trigno, AD Instruments, NZ) will be recorded from quadriceps and hamstrings, while knee strength will be assessed with an isokinetic dynamometer (Humac Norm, USA). Standardized electrode placement and contraction protocols will ensure reproducibility. During testing, single- and paired-pulse TMS protocols will be applied at 10% of maximal voluntary contraction. Ten stimuli per condition will be collected, providing reliable estimates of excitability and inhibition. Visual feedback will help participants maintain the required contraction level throughout assessments. Statistical analysis will begin with normality testing (Shapiro-Wilk). Linear mixed models (Time × Cue condition) will be used for primary and secondary outcomes. Post-hoc comparisons will use Bonferroni corrections. Synchronization accuracy will be compared with paired t-tests. Statistical significance will be set at p < 0.05, and analyses will be performed using Jamovi software. This protocol is designed to rigorously test whether fractal cueing can restore healthy gait variability patterns and enhance corticospinal excitability in athletes with ACL reconstruction, compared with conventional isochronous cueing.

Being tested
Fractal Cueing, Isochronous Cueing
Keywords
Complexity, Excitability, Metronome, Neuroplasticity, Rehabilitation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fractal CueingDevice

    Walking synchronized to a visual fractal metronome.

  • Isochronous CueingDevice

    Walking synchronized to a visual Isochronous metronome.

Study groups in NCT07243535
Study groupRoleWhat they receive
Fractal Cueing, Then Isochronous CueingExperimentalParticipants exposed to 12-minute treadmill walking synchronized to a visual fractal metronome individualized to stride time variability. After a washout period of 1 week, participants will be exposed to 12-minute treadmill walking synchronized to a visual isochronous metronome with fixed stride time.
Receives: Device: Fractal Cueing; Device: Isochronous Cueing
Isochronous Cueing, then Fractal cueingExperimentalParticipants exposed to 12-minute treadmill walking synchronized to a visual isochronous metronome with fixed stride time. After a washout period of 1 week, participants will be exposed to 12-minute treadmill walking synchronized to a visual fractal metronome individualized to stride time variability.
Receives: Device: Fractal Cueing; Device: Isochronous Cueing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gait Variability Measured by Fractal Scaling Exponent of inter-stride intervals

    The fractal-scaling exponent, α, of inter-stride intervals (α-ISIs) will be determine by calculating the time between two consecutive heel strikes of the same foot. First, the investigators will identify the heel strike events of the dominant foot. To improve the identification of this event, the signals will be filtered using a 2nd order, zero lag low-pass Butterworth filter with a cutoff frequency of 20 Hz. Then, Detrended Fluctuation Analysis (DFA) will be used to determine the fractal-scaling, an index of complexity. The DFA is a modified random-walk analysis that makes use of a long-range correlated time series. The long-range correlation can be mapped to self-similar calculations through simple integration.

    Measured: Pre- (40 minutes before) and Post- (40 minutes after) -Intervention

  2. Corticospinal Excitability Measured by Motor Evoked Potential Amplitude

    Conducted using Spike2 software (version 10; Cambridge Electronic Design, Cambridge, United Kingdom) and subsequently exported to, MATLAB R2018a (The MathWorks, Natick, Massachusetts, United States) for processing and analysis. Corticospinal Excitability will be quantified as the peak-to-peak amplitude of MEPs elicited by a single-pulse TMS stimulus, with values averaged across 10 trials per participant.

    Measured: Baseline (Pre) and immediately after the intervention (Post)

  3. Cortical Silent Period (SP) Duration

    Silent period will be calculated as the time from MEP onset to the resumption of voluntary EMG activity, expressed as SP = resumption of voluntary EMG time - MEP onset (58), and averaged across all 10 stimuli.

    Measured: Baseline (Pre) and immediately after the intervention (Post)

  4. Intracortical Facilitation (ICF)

    ICF will be determined using the same calculation method but with an interstimulus interval of 12 ms (ICF = conditioned MEP / control MEP).

    Measured: Baseline (Pre) and immediately after the intervention (Post)

  5. Short-Interval Intracortical Inhibition (SICI)

    SICI will be calculated as the ratio between the conditioned MEP elicited with a paired-pulse TMS protocol (interstimulus interval: 3 ms) and a control MEP obtained from AMT assessment, expressed as SICI = conditioned MEP / control MEP.

    Measured: Baseline (Pre) and immediately after the intervention (Post)

Secondary outcomes (2)
  1. Magnitude of variability

    Calculate the coefficient of variation of inter-stride intervals, representing the magnitude of variability.

    Measured: Pre- (40 minutes before) and Post- (40 minutes after) -Intervention

  2. Synchronization Accuracy

    Asynchronies (ASYNC), i.e., the time difference between the heel strikes and the cues, expressed in milliseconds. This will be used to ensure that differences at the primary outcome are not the result of different synchronization performances. A negative value of ASYNC indicates that the heel strike occurred before the cue. The ASYNC provides information regarding the strategies used and the performance of the synching processes, serving as a control parameter to reliably interpret our results in terms of gait complex.

    Measured: During Intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Nov 2025
  2. Study start3 Oct 2025
  3. Primary completionNov 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Model description
This study is a crossover randomized controlled trial, comprising two sessions. Each session will take approximately 2 hours, and the sessions will be separated from 7 to 10 days. Both sessions will be held at the same period of the day to avoid the circadian effect on our primary outcome. The two sessions will be similar. At the beginning of the first session, however, three questionnaires will be administered to collect the demographic and baseline characteristics of the participants. Following the completion of these questionnaires, a randomization process through a fixed block method will be conducted by the study's supervisor to determine the order in which the intervention will be presented across the two sessions. The participants will be asked to complete three 12-minute gait trials in each session: one cued trial and two uncued trials. A minimum of 20 minutes of rest will be taken between each trial while collecting the cortical drive assessment, PRE and POST the cued trial.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
36 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07243535
Sponsor's protocol ID
SyncGait-5725
Acronym
SyncGait
Status last verified
Sep 2026
First submitted
16 Sep 2025
Last updated
11 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All raw data will be stored in the supervisor's institutional personal Microsoft 365 account for five years, after which it will be permanently deleted. Data will be recorded anonymously using a unique coded numerical ID, known only to the supervisor. The database will be in Excel format. The encoded dataset may be shared with the rest of the research team and the journal where the study will be published, which may, in turn, make the data available to the scientific community for one year following publication.

Publications

  • Grooms DR, Page SJ, Nichols-Larsen DS, Chaudhari AM, White SE, Onate JA. Neuroplasticity Associated With Anterior Cruciate Ligament Reconstruction. J Orthop Sports Phys Ther. 2017 Mar;47(3):180-189. doi: 10.2519/jospt.2017.7003. Epub 2016 Nov 5.

    PubMed 27817301
  • Bodkin SG, Bruce AS, Hertel J, Diduch DR, Saliba SA, Novicoff WM, Hart JM. Visuomotor therapy modulates corticospinal excitability in patients following anterior cruciate ligament reconstruction: A randomized crossover trial. Clin Biomech (Bristol). 2021 Jan;81:105238. doi: 10.1016/j.clinbiomech.2020.105238. Epub 2020 Nov 20.

    PubMed 33234323
  • Moraiti CO, Stergiou N, Vasiliadis HS, Motsis E, Georgoulis A. Anterior cruciate ligament reconstruction results in alterations in gait variability. Gait Posture. 2010 Jun;32(2):169-75. doi: 10.1016/j.gaitpost.2010.04.008. Epub 2010 Jun 29.

    PubMed 20591671
  • Vaz JR, Groff BR, Rowen DA, Knarr BA, Stergiou N. Synchronization dynamics modulates stride-to-stride fluctuations when walking to an invariant but not to a fractal-like stimulus. Neurosci Lett. 2019 Jun 21;704:28-35. doi: 10.1016/j.neulet.2019.03.040. Epub 2019 Mar 25.

    PubMed 30922850
  • Vaz JR, Knarr BA, Stergiou N. Gait complexity is acutely restored in older adults when walking to a fractal-like visual stimulus. Hum Mov Sci. 2020 Dec;74:102677. doi: 10.1016/j.humov.2020.102677. Epub 2020 Oct 15.

    PubMed 33069099

Questions about this trial

What is this clinical trial studying?

A study testing Fractal Cueing and Isochronous Cueing in people with Anterior Cruciate Ligament Reconstruction and Anterior Cruciate Ligament Reconstruction Rehabilitation, run by Egas Moniz - Cooperativa de Ensino Superior, CRL at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 11 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Inês D Ribeiro, MSC Student ((+351) 964 544 607, 115360@alunos.egasmoniz.edu.pt), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gait Variability Measured by Fractal Scaling Exponent of inter-stride intervals (time frame: Pre- (40 minutes before) and Post- (40 minutes after) -Intervention). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07243535, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in